Life sciences and photonics company PerkinElmer Inc. of Waltham, Mass., announced that Alan Fletcher, PhD, has joined the company as vice president of business development for its Life and Analytical Sciences business.  Fletcher will be responsible for growing the biodiscovery business through strategic partnerships and alliances in life science research, and introducing new technologies for GPCR, kinase and biomarker drug target classes. Fletcher, a 20-year veteran of the drug discovery and life science industries, joins PerkinElmer from GE Healthcare, where he held several positions in the company's life science and discovery systems business units. Prior to this, Fletcher held leadership roles for several companies in the areas of consumer products, biotechnology, R&D, and technology transfer. He has a doctorate in biochemical pharmacology from the University of London and has published papers on drug discovery and high throughput screening. Fletcher has served on the board of the Society of Biomolecular Sciences since 2002.